Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
25 06 2020
Historique:
received: 27 11 2019
revised: 11 03 2020
accepted: 28 04 2020
pubmed: 30 5 2020
medline: 22 1 2021
entrez: 30 5 2020
Statut: ppublish

Résumé

Brain malignancies can either originate from within the CNS (gliomas) or invade from other locations in the body (metastases). A highly immunosuppressive tumor microenvironment (TME) influences brain tumor outgrowth. Whether the TME is predominantly shaped by the CNS micromilieu or by the malignancy itself is unknown, as is the diversity, origin, and function of CNS tumor-associated macrophages (TAMs). Here, we have mapped the leukocyte landscape of brain tumors using high-dimensional single-cell profiling (CyTOF). The heterogeneous composition of tissue-resident and invading immune cells within the TME alone permitted a clear distinction between gliomas and brain metastases (BrM). The glioma TME presented predominantly with tissue-resident, reactive microglia, whereas tissue-invading leukocytes accumulated in BrM. Tissue-invading TAMs showed a distinctive signature trajectory, revealing tumor-driven instruction along with contrasting lymphocyte activation and exhaustion. Defining the specific immunological signature of brain tumors can facilitate the rational design of targeted immunotherapy strategies.

Identifiants

pubmed: 32470397
pii: S0092-8674(20)30561-4
doi: 10.1016/j.cell.2020.04.055
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02451423']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1626-1642.e20

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Ekaterina Friebel (E)

Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.

Konstantina Kapolou (K)

Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich 8091, Switzerland.

Susanne Unger (S)

Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.

Nicolás Gonzalo Núñez (NG)

Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.

Sebastian Utz (S)

Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.

Elisabeth Jane Rushing (EJ)

Department of Neuropathology, University Hospital Zurich and University of Zurich, Zurich 8091, Switzerland.

Luca Regli (L)

Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich 8091, Switzerland.

Michael Weller (M)

Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich 8091, Switzerland.

Melanie Greter (M)

Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.

Sonia Tugues (S)

Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.

Marian Christoph Neidert (MC)

Laboratory of Molecular Neuro-Oncology, Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich 8091, Switzerland; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich 8091, Switzerland.

Burkhard Becher (B)

Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland. Electronic address: becher@immunology.uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH